A practical guide for expanding across sites without increasing compliance risk. Specifically for accounts with GMP and Non-GMP sites
- When expansion creates risk (and when it doesn’t)
- Adding sites vs. standardizing networks (clear distinction)
- Validation effort at scale
- What “good” looks like at 3, 10, 25+ sites
Who it’s for:
Directors+ in Quality, Facilities, Ops, IT
People who already know expansion is coming
This becomes the single source of truth you can point to when someone asks:
“Should we standardize now or later?”
“Why does expansion suddenly feel harder?”
“How do other companies avoid revalidating everything?”